Herring oil: a new weapon against aching joints?
NCT ID NCT07786181
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This study tests whether marine oil supplements, particularly those rich in omega-11 fatty acids, can reduce joint pain and stiffness in adults aged 50-75 with mild to moderate joint discomfort. Participants will take daily capsules of either herring oil, a high-omega-11 concentrate, or a control fish oil for six months. Researchers will measure changes in joint inflammation, pain, and stiffness to see if these oils offer relief.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Marine oil supplements (herring oil with regular or high omega-11 content, or a commercial fish oil)
- What this could lead to
- If effective, these marine oils could offer a natural way to ease joint pain and stiffness, improving daily life for many adults.
- What could go wrong
- This is an early-stage trial, and results may not show a clear benefit. Some people may experience digestive upset or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults (50-75 years) * Mild to moderate joint pain for at least 3 months * Stable body weight last 3 months Exclusion Criteria: * Diagnosed reumatic disease * Allergies towards fish, milk, egg, gluten * Daily tobacco use (cigarettes or snus) * Serious illness (cardiovascular disease, neurological disease, cancer, diseases affecting intestinal function, kidney function or insulin secretion) * Use of medications targeting cholesterol or glucose metabolism * Use of dietary supplements * Pregnant or breastfeeding * Following a strict diet * Had bariatric surgery or using medications for weight loss * Recent or planned surgical procedures * High intake of fish/seafood
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Joint function are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Menthol and copaiba cream put to the test for joint pain relief
- Could a daily supplement combo ease joint pain and fatigue in midlife women?
- Could a daily supplement ease joint pain, fatigue, and sleep troubles in middle age?
- Your iPhone could help monitor psoriasis: new study tests smartphone tracking
- Can a simple test predict who will beat chronic pain?
- New gout pill aims to stop flare pain in 3 days